FAMILIAL PHEOCHROMOCYTOMA - SUCCESSFUL TREATMENT WITH I-131 MIBG

被引:14
|
作者
GONCALVES, E
NINANE, J
WESE, FX
LEONET, J
PIRET, L
CORNU, G
DEMEYER, R
机构
[1] CLIN UNIV ST LUC,DEPT PAEDIAT HEMATOL & ONCOL,AVE HIPPOCRATE 10,B-1200 BRUSSELS,BELGIUM
[2] CLIN UNIV ST LUC,DEPT PAEDIAT,B-1200 BRUSSELS,BELGIUM
[3] CLIN UNIV ST LUC,DEPT NUCL MED,B-1200 BRUSSELS,BELGIUM
[4] CLIN UNIV ST LUC,DEPT PAEDIAT UROL,B-1200 BRUSSELS,BELGIUM
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1990年 / 18卷 / 02期
关键词
APUDoma; familial; MIBG; phaeochromocytoma; treatment;
D O I
10.1002/mpo.2950180208
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the case of a family in which the mother died of hypertensive encephalopathy following the relapse of a phaeochromocytoma. Two of her children are still alive. Both children had malignant phaeochromocytomas that have been treated by surgery and 131I‐MIBG. The first child presented with phaeochromocytoma of the right suprarenal gland at the age of 7 years. Surgery was performed. At the age of 14 years, he developed a tumour of the left suprarenal gland and two pulmonary metastases demonstrated by 131‐MIBG. The three tumours were removed, but new lesions occurred. The boy then was treated with 200 mCi (7,400 MBq) of 131‐MIBG given twice, and is now free of disease more than 2 years after treatment. His sister presented at the age of 12 years with phaeochromocytoma of the left suprarenal gland, the only lesion recognized by 131I‐MIBG. The tumour was removed, but 5 months later, she developed phaeochromocytoma in the right suprarenal gland. She was treated with 200 mCi (7,400 MBq) of 131I‐MIBG and surgery was performed 6 months later. Histology of the suprarenal gland could not demonstrate the persistence of phaeochromocytoma cells. The child is now free of disease more than 2 years after treatment. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:126 / 130
页数:5
相关论文
共 50 条
  • [1] MALIGNANT PHEOCHROMOCYTOMA TREATED BY I-131 MIBG
    MCDOUGALL, IR
    JOURNAL OF NUCLEAR MEDICINE, 1984, 25 (02) : 249 - 251
  • [2] I-131 MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
    Gedik, G. K.
    Hoefnagel, C. A.
    Bais, E.
    Olmos, R. A. Valdes
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S241 - S241
  • [3] PHEOCHROMOCYTOMA IN THE ORGAN OF ZUKERKANDL - I-131 MIBG SCINTIGRAPHIC LOCALIZATION
    ELDESOUKI, M
    ALNUAIM, A
    MOFTI, A
    SHANNA, A
    CLINICAL NUCLEAR MEDICINE, 1989, 14 (06) : 446 - 448
  • [4] I-131 META-IODOBENZYLGUANIDINE (I-131-MIBG) FOR THE LOCALIZATION OF SUSPECTED PHEOCHROMOCYTOMA
    WARREN, MJ
    SHEPSTONE, BJ
    SOPER, N
    NUCLEAR MEDICINE COMMUNICATIONS, 1989, 10 (07) : 467 - 475
  • [5] THERAPY OF MALIGNANT PHEOCHROMOCYTOMA WITH I-131 META-IODOBENZYLGUANIDINE (MIBG)
    MCEWAN, AJ
    BLAKE, G
    HALL, VL
    ACKERY, DM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1985, 11 (2-3): : A17 - A17
  • [6] TREATMENT OF MALIGNANT PHEOCHROMOCYTOMA WITH I-131 METAIODOBENZYLGUANIDINE
    BEUTTER, D
    CHATAL, JF
    BRUNET, G
    CHARBONNEL, B
    ANNALES D ENDOCRINOLOGIE, 1987, 48 (01) : 53 - 57
  • [7] LABETALOL REDUCES I-131 MIBG UPTAKE BY PHEOCHROMOCYTOMA AND NORMAL-TISSUES
    KHAFAGI, FA
    SHAPIRO, B
    FIG, LM
    MALLETTE, S
    SISSON, JC
    JOURNAL OF NUCLEAR MEDICINE, 1989, 30 (04) : 481 - 489
  • [8] Clinical Dosimetry Tool Implementation of I-131 MIBG Therapy for Pheochromocytoma and Paraganglioma
    Franco, R. Perez
    Pugachev, A.
    MEDICAL PHYSICS, 2020, 47 (06) : E519 - E519
  • [9] CALCULATING RADIATION ABSORBED DOSE FOR PHEOCHROMOCYTOMA TUMORS IN I-131 MIBG THERAPY
    KORAL, KF
    WANG, XH
    SISSON, JC
    BOTTI, J
    MEYER, L
    MALLETTE, S
    GLAZER, GM
    ADLER, RS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (01): : 211 - 218
  • [10] EXTRA-ADRENAL AND METASTATIC PHEOCHROMOCYTOMA - THE ROLE OF I-131 META-IODOBENZYLGUANIDINE (I-131 MIBG) IN LOCALIZATION AND MANAGEMENT
    THOMPSON, NW
    ALLO, MD
    SHAPIRO, B
    SISSON, JC
    BEIERWALTES, W
    WORLD JOURNAL OF SURGERY, 1984, 8 (04) : 605 - 611